In the field of functional proteomics,the human disease proteomics shows great potential in the discovery of new molecular targets and biomarkers for medicine and biopharmacy.
In the second part, we detected serum NMO-IgG of patients with neuromyelitis optica, multiple sclerosis and health people to verify whether NMO-IgG can be a biomarker for neuromyelitis optica.
One study showed therapeutic blood letting improved biomarkers for patients with non-alcoholic fatty liver disease, a condition that commonly appears with diabetes.